The main objective of this project is to test whether EMDR therapy is effective in reducing substance use and improving clinical and trauma-related symptoms in SUD patients with a history of psychological trauma.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Reduction in severity of consumption
Timeframe: Changes from baseline to visits at 3, 6 and 12 months.
Reduction in level of consumption
Timeframe: Changes from baseline to visits at 3, 6 and 12 months.
Reduction in the number of relapses
Timeframe: Change of relapses from baseline to visits at 3, 6 and 12 months.
Reduction of (hypo) manic symptoms associated with a comorbid psychiatric disorder
Timeframe: Changes from baseline to visits at 6 and 12 months.
Reduction of general psychopathological symptoms associated with psychiatric comorbidity
Timeframe: Change from baseline to visits at 6 and 12 months.
Reduction in depressive symptoms associated with a comorbid psychiatric disorder
Timeframe: Changes from baseline to visits at 6 and 12 months.